Skip to content
Stay informed with SureHeadline's coverage of breaking news…

The Zimbabwean Government Declines ‘One-Sided’ American Health Aid Package Over Data Concerns

Medical funding image
The offered American funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a major American health deal worth $367m (£272m) spanning five years over the United States' demand for confidential biological samples.

The decision came to light after a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "skewed".

A government spokesman has since stated that the US was seeking genetic material for research and commercial purposes while refused to share the resulting advantages from any future medical innovations.

"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged continued dialogue to find a deal suitable to all parties so the nation's vital HIV treatment initiative can be sustained.

Wider Background

Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court suspended a related health funding agreement following concerns were filed about the security of Kenyans' health data.

Since resuming office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

USAID had administered aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government deals to enhance transparency and accountability.

As per statements, 16 African countries have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment through US-supported initiatives," Tremont said.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any corresponding guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.

"In essence, our country would provide the raw materials for medical research without any assurance that the final treatments would be accessible to our citizens if a future health crisis arise."

Sovereignty and International Frameworks

He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously established through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.

"This framework is designed to guarantee that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We encourage continued dialogue with our US partners on how subsequent co-operation might be arranged in a way that honours the independence and dignity of each country."

Medical Community Response

Medical experts expressed it understood the official position, but suggested that talks need to persist since much of the nation's Aids initiatives depended on external financing.

"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it said.

The situation highlights the complex debate between receiving crucial foreign assistance and safeguarding local interests in an ever more interconnected world.

Written by

Sandra Mayo

Award-winning journalist with over a decade of experience covering international affairs and investigative reporting.

SureHeadline

Type to search articles.